https://www.marketscreener.com/quote/stock/BIOCRYST-PHARMACEUTICALS--8534/news/FDA-Grants-Orphan-Drug-Designation-for-BioCryst-s-ALK-2-Inhibitor-BCX9250-for-the-Treatment-of-F-41657814/?utm_source=telegram&utm_medium=social&utm_campaign=share